BioMarin Pharmaceutical Inc. (BMV:BMRN)

BioMarin Pharmaceutical Statistics

Total Valuation

BMV:BMRN has a market cap or net worth of MXN 204.26 billion. The enterprise value is 188.47 billion.

Market Cap	204.26B
Enterprise Value	188.47B

Important Dates

The last earnings date was Monday, February 23, 2026.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	192.32M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	98.61%
Float	191.45M

Valuation Ratios

The trailing PE ratio is 32.52 and the forward PE ratio is 11.06.

PE Ratio	32.52
Forward PE	11.06
PS Ratio	3.52
PB Ratio	1.86
P/TBV Ratio	2.03
P/FCF Ratio	15.65
P/OCF Ratio	13.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.92, with an EV/FCF ratio of 14.44.

EV / Earnings	30.01
EV / Sales	3.40
EV / EBITDA	14.92
EV / EBIT	16.83
EV / FCF	14.44

Financial Position

The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.11.

Current Ratio	5.21
Quick Ratio	3.25
Debt / Equity	0.11
Debt / EBITDA	0.88
Debt / FCF	0.89
Interest Coverage	59.71

Financial Efficiency

Return on equity (ROE) is 5.94% and return on invested capital (ROIC) is 9.09%.

Return on Equity (ROE)	5.94%
Return on Assets (ROA)	5.58%
Return on Invested Capital (ROIC)	9.09%
Return on Capital Employed (ROCE)	9.52%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	18.00M
Profits Per Employee	1.95M
Employee Count	3,221
Asset Turnover	0.44
Inventory Turnover	0.47

Taxes

In the past 12 months, BMV:BMRN has paid 2.40 billion in taxes.

Income Tax	2.40B
Effective Tax Rate	27.69%

Stock Price Statistics

The stock price has decreased by -25.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.50%
50-Day Moving Average	1,355.23
200-Day Moving Average	1,607.72
Relative Strength Index (RSI)	40.54
Average Volume (20 Days)	141

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.44

Income Statement

In the last 12 months, BMV:BMRN had revenue of MXN 57.99 billion and earned 6.28 billion in profits. Earnings per share was 32.49.

Revenue	57.99B
Gross Profit	47.22B
Operating Income	11.72B
Pretax Income	8.69B
Net Income	6.28B
EBITDA	13.01B
EBIT	11.72B
Earnings Per Share (EPS)	32.49

Balance Sheet

The company has 28.10 billion in cash and 11.57 billion in debt, with a net cash position of 16.52 billion.

Cash & Cash Equivalents	28.10B
Total Debt	11.57B
Net Cash	16.52B
Net Cash Per Share	n/a
Equity (Book Value)	109.59B
Book Value Per Share	569.87
Working Capital	57.51B

Cash Flow

In the last 12 months, operating cash flow was 14.91 billion and capital expenditures -1.86 billion, giving a free cash flow of 13.05 billion.

Operating Cash Flow	14.91B
Capital Expenditures	-1.86B
Free Cash Flow	13.05B
FCF Per Share	n/a

Margins

Gross margin is 81.43%, with operating and profit margins of 20.20% and 10.83%.

Gross Margin	81.43%
Operating Margin	20.20%
Pretax Margin	14.98%
Profit Margin	10.83%
EBITDA Margin	22.44%
EBIT Margin	20.20%
FCF Margin	22.51%

Dividends & Yields

BMV:BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	3.08%
FCF Yield	6.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:BMRN has an Altman Z-Score of 5.77 and a Piotroski F-Score of 6.

Altman Z-Score	5.77
Piotroski F-Score	6